Latest Breaking News On - Prashant kohli - Page 1 : vimarsana.com

Acasti Pharma to Attend BIO International Convention 2024

EdTech platform Newton School appoints Prashant Kohli as Senior Director, Marketing: Best Media Info

Startup news and updates: daily roundup (February 15, 2024)

Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company ad.

Acasti Announces Second Quarter 2024 Financial Results and Business Highlights

From doomscrolling to thumpstopping: How brands aim to combat digital fatigue

From doomscrolling to thumb-stopping: How brands aim to combat digital fatigue

Acasti Announces First Quarter 2024 Financial Results and Business Highlights

New leadership team singularly focused on executing GTX-104 strategyAnnounced alignment with the U.S. Food and Drug Administration (FDA) for Pivot.

Form 8-K Acasti Pharma Inc. For: Jul 24

Acasti appoints WuXi to oversee STRIVE-ON trial

Acasti Pharma, a late-stage biopharma company with drug candidates addressing rare and orphan diseases, has selected WuXi Clinical Development to conduct its STRIVE-ON phase 3 safety trial for GTX-104, a novel injectable nimodipine formulation for intravenous infusion (IV) that addresses high, unmet medical needs for aneurysmal subarachnoid haemorrhage (aSAH).

Acasti Pharma Announces 1-for-6 Reverse Stock Split

/PRNewswire/ Acasti Pharma Inc. ("Acasti" or the "Company") (Nasdaq: ACST), a late-stage, biopharma company advancing GTX-104, its novel formulation of.